MF6.DE
MagForce AG [MF6.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MF6.DE Stock Summary
In the News
MF6.DE Financial details
Company Rating
Neutral
Market Cap
3.49M
Income
-10.57K
Revenue
1.08K
Book val./share
896.74
Cash/share
3.83
Dividend
-
Dividend %
-
Employees
33
Optionable
No
Shortable
Yes
Earnings
27 Jun 2024
P/E
0
Forward P/E
-
PEG
-
P/S
9.91
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.14
Current Ratio
0.19
Debt / Equity
0.96
LT Debt / Equity
0.96
-
-
EPS (TTM)
-0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-70758%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
317.06%
Revenue last 5Y
-13.24%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-34%
ROC
-0.12%
Gross Margin
-90%
Oper. Margin
-1914%
Profit Margin
-3004%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.11-3.94
52W High
-
52W Low
-
RSI
-
Rel Volume
1.74
Avg Volume
50.74K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
3.018
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
MF6.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.03 | 0 | 0.03 | 0.02 | 11.76 | |
| Net income per share | -0.28 | 0.16 | -0.32 | 0.5 | -353.29 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.03 | 0.06 | 1.12 | 1.98 | 1.89K | |
| Book value per share | 0.5 | 0.69 | 0.53 | 1.21 | 896.74 | |
| Tangible book value per share | 0.5 | 0.68 | 0.5 | 1.15 | 831.14 | |
| Share holders equity per share | 0.5 | 0.69 | 0.53 | 1.21 | 896.74 | |
| Interest debt per share | 0.22 | 0.67 | 0.66 | 0.88 | 954.93 | |
| Market cap | 169.16M | 142.11M | 110.82M | 146.2M | 81.41K | |
| Enterprise value | 173.9M | 156.49M | 127.33M | 167.32M | 25.61M | |
| P/E ratio | -22.66 | 32.61 | -12.69 | 9.91 | -0.01 | |
| Price to sales ratio | 236.21 | 2.11K | 131.94 | 235.38 | 0.23 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 12.82 | 7.83 | 7.53 | 4.12 | 0 | |
| PTB ratio | 12.82 | 7.83 | 7.53 | 4.12 | 0 | |
| EV to sales | 242.84 | 2.33K | 151.59 | 269.38 | 72.75 | |
| Enterprise value over EBITDA | -29.17 | 20.44 | -24.59 | 8.49 | -4.55 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | -0.04 | 0.03 | -0.08 | 0.1 | -129.89 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.41 | 0.88 | 1.13 | 0.64 | 0.96 | |
| Debt to assets | 0.25 | 0.43 | 0.45 | 0.35 | 0.41 | |
| Net debt to EBITDA | -0.8 | 1.88 | -3.19 | 1.07 | -4.54 | |
| Current ratio | 1.01 | 2.98 | 0.58 | 1.01 | 0.19 | |
| Interest coverage | -27.96 | 3.75 | -3.42 | 6.13 | -2.29 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.68 | 5.82 | 0.65 | 0.7 | 0.94 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0.02 | 0.02 | 0.03 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.79 | 1.59 | 1.94 | 3.7 | 2.67K | |
| ROIC | -0.4 | 0.2 | -0.18 | 0.32 | -0.13 | |
| Return on tangible assets | -0.34 | 0.12 | -0.24 | 0.23 | -0.17 | |
| Graham Net | -0.3 | -0.63 | 0.37 | 1 | 714.65 | |
| Working capital | 13.34K | 1.77M | -1.21M | 35.95K | -5.5M | |
| Tangible asset value | 13.19M | 18.07M | 13.94M | 33.89M | 24.88M | |
| Net current asset value | -7.48M | -16.31M | -20.27M | -26.28M | -34.68M | |
| Invested capital | 0.41 | 0.88 | 1.13 | 0.64 | 0.96 | |
| Average receivables | 454.25K | 533.94K | 909.87K | 1.22M | 1.09M | |
| Average payables | 255.08K | 295.31K | 508.86K | 489.43K | 474.91K | |
| Average inventory | 186.37K | 296.27K | 310.98K | 333.6K | 315.14K | |
| Days sales outstanding | 168.81 | 4K | 470.65 | 800.51 | 837.87 | |
| Days payables outstanding | 133.64 | 273.08 | -4.61K | 590.68 | 353.78 | |
| Days of inventory on hand | 161.2 | 233.3 | -2.25K | 658.18 | 160.5 | |
| Receivables turnover | 2.16 | 0.09 | 0.78 | 0.46 | 0.44 | |
| Payables turnover | 2.73 | 1.34 | -0.08 | 0.62 | 1.03 | |
| Inventory turnover | 2.26 | 1.56 | -0.16 | 0.55 | 2.27 | |
| ROE | -0.57 | 0.24 | -0.59 | 0.42 | -0.39 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-12-31 for Q4
| Metric | History | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net income per share | 0.33 | -0.09 | -0.09 | -0.09 | -0.09 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 58.12 | 0.02 | 22.07 | 0 | 3.83 | |
| Book value per share | 1.21K | -0.73 | 1.05K | -0.89 | 896.74 | |
| Tangible book value per share | 1.15K | -1.18 | 987.38 | -1.25 | 831.14 | |
| Share holders equity per share | 1.21K | -0.73 | 1.05K | -0.89 | 896.74 | |
| Interest debt per share | 777.47 | 0.53 | 903.47 | 0.6 | 856.66 | |
| Market cap | 146.2K | 129.93K | 109.01K | 97.28K | 81.41K | |
| Enterprise value | 21.27M | 129.28K | 26.08M | 97.16K | 25.61M | |
| P/E ratio | 3.73 | -12.85 | -10.78 | -8.81 | -7.37 | |
| Price to sales ratio | 316.95 | 749.31 | 628.67 | 266.38 | 222.94 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | -6 | 0 | -3.64 | 0 | |
| PTB ratio | 0 | -6 | 0 | -3.64 | 0 | |
| EV to sales | 46.1K | 745.56 | 150.39K | 266.07 | 70.13K | |
| Enterprise value over EBITDA | -12.44K | -95.05 | -19.17K | -63.81 | -16.82K | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.07 | -0.02 | -0.02 | -0.03 | -0.03 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.64 | -0.75 | 0.86 | -0.7 | 0.96 | |
| Debt to assets | 0.35 | 0 | 0.41 | 0 | 0.41 | |
| Net debt to EBITDA | -12.35K | 0.48 | -19.09K | 0.08 | -16.76K | |
| Current ratio | 1.01 | 0.18 | 0.82 | 0.13 | 0.19 | |
| Interest coverage | 1.99 | 2.28 | 2.28 | 2.44 | 2.44 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0 | 0.03 | 0 | 0.03 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 95.38 | 1.19 | 44.96 | 1.36 | 43.14 | |
| ROIC | 0 | 0.28 | 0 | 0.21 | 0 | |
| Return on tangible assets | 0 | 1.87 | 0 | 1.78 | 0 | |
| Graham Net | -925.84 | -1.11 | -1.08K | -1.19 | -1.17K | |
| Working capital | 35.95K | -9.77K | -594.83K | -7.61K | -5.5M | |
| Tangible asset value | 33.89M | -34.79K | 29.09M | -37.54K | 24.88M | |
| Net current asset value | -26.28M | -31.33K | -30.78M | -34.88K | -34.68M | |
| Invested capital | 0.64 | -0.75 | 0.86 | -0.7 | 0.96 | |
| Average receivables | 681.14K | 681.14K | 500.5K | 500.5K | 403.99K | |
| Average payables | 151.16K | 151.09K | 185.45K | 185.59K | 324.35K | |
| Average inventory | 168.22K | 168.32K | 267.1K | 267.04K | 147.11K | |
| Days sales outstanding | 265.79K | 0 | 519.56K | 0 | 199.14K | |
| Days payables outstanding | 159.6K | 148.35 | 142.57K | 262.65 | 258.66K | |
| Days of inventory on hand | 177.84K | 137.01 | 205.42K | 90.47 | 117.35K | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0.61 | 0 | 0.34 | 0 | |
| Inventory turnover | 0 | 0.66 | 0 | 0.99 | 0 | |
| ROE | 0 | 0.12 | 0 | 0.1 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
MF6.DE Frequently Asked Questions
What is MagForce AG stock symbol ?
MagForce AG is a DE stock and trading under the symbol MF6.DE
What is MagForce AG stock quote today ?
MagForce AG stock price is $- today.
Is MagForce AG stock public?
Yes, MagForce AG is a publicly traded company.
Company Profile
- Volume Average 50.74K
- Market Capitalization 3.49M
- Employee 33
- CEO Dr. Benjamin J. Lipps
- Headquarters Berlin,DE
- IPO Date 2007-09-21
-
Website
https://www.magforce.com 
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
